In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Delhi Excise Policy Case The Delhi High Court will hear the petition of Chief Minister Arvind Kej
Transformers Rise Of The Beasts Review: The flight of imagination in Hollywood cinema has attaine
Natasha Stankovic and Hardik Pandya split after announcing their divorce in July this year. Meanw
Russia and Ukraine War: Missiles hit the dam in Ukraine, and people were ordered to evacuate
Residents of Krivoy Rih, Ukraine, have been asked to evacuate after missiles hit a large reservoi
RBI Governor Shaktikanta Das said inflation is the biggest concern for the economy
Despite the spurt in economic activity, the persistently high rate of inflation remains the bigge
PM Modi speaks to Vladimir Putin, reiterates India's stand on the situation in Ukraine
Prime Minister Narendra Modi had a phone conversation with Russian President Vladimir Putin on Fr
British Prime Minister Rishi Sunak has lambasted China in his first speech on foreign policy. Sun
108MP Camera Phone: Buy Xiaomi's phone worth Rs 49,999 in an Amazon deal for just Rs 29,999!
108MP Camera Phone On Amazon: Amazon has started phone deals even before the Great Freedom Festiv
Madhya Pradesh's Higher Education Minister Mohan Yadav compared the life of Mother Sita to the li
There is a contradiction between Rahul's statement on the President's address in the Lok Sabha an
